- Home
- NBTX vs KINS Comparison
NBTX vs KINS Comparison
Compare NBTX & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- KINS
- Stock Information
- Founded
- NBTX 2003
- KINS 1886
- Country
- NBTX France
- KINS United States
- Employees
- NBTX N/A
- KINS N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- KINS Property-Casualty Insurers
- Sector
- NBTX Health Care
- KINS Finance
- Exchange
- NBTX Nasdaq
- KINS Nasdaq
- Market Cap
- NBTX 178.7M
- KINS 197.1M
- IPO Year
- NBTX 2020
- KINS N/A
- Fundamental
- Price
- NBTX $3.61
- KINS $16.99
- Analyst Decision
- NBTX Strong Buy
- KINS Strong Buy
- Analyst Count
- NBTX 1
- KINS 1
- Target Price
- NBTX $12.00
- KINS $6.50
- AVG Volume (30 Days)
- NBTX 13.1K
- KINS 299.5K
- Earning Date
- NBTX 04-23-2025
- KINS 03-13-2025
- Dividend Yield
- NBTX N/A
- KINS N/A
- EPS Growth
- NBTX N/A
- KINS N/A
- EPS
- NBTX N/A
- KINS 1.48
- Revenue
- NBTX $45,220,186.00
- KINS $155,142,103.00
- Revenue This Year
- NBTX N/A
- KINS $39.05
- Revenue Next Year
- NBTX N/A
- KINS $3.26
- P/E Ratio
- NBTX N/A
- KINS $11.89
- Revenue Growth
- NBTX 526.17
- KINS 7.59
- 52 Week Low
- NBTX $2.76
- KINS $3.93
- 52 Week High
- NBTX $7.51
- KINS $19.18
- Technical
- Relative Strength Index (RSI)
- NBTX 52.08
- KINS 56.09
- Support Level
- NBTX $3.32
- KINS $16.20
- Resistance Level
- NBTX $3.77
- KINS $17.77
- Average True Range (ATR)
- NBTX 0.21
- KINS 1.00
- MACD
- NBTX 0.01
- KINS 0.28
- Stochastic Oscillator
- NBTX 60.55
- KINS 81.94
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About KINS Kingstone Companies Inc.
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.